Adenovirus-mediated transfer of wild-type p53 gene sensitizes TNF resistant MCF7 derivatives to the cytotoxic effect of this cytokine:: relationship with c-myc and Rb

被引:35
作者
Ameyar, M
Shatrov, V
Bouquet, C
Capoulade, C
Cai, ZZ
Stancou, R
Badie, C
Haddada, H
Chouaib, S [1 ]
机构
[1] Inst Gustave Roussy, INSERM, U487, F-94805 Villejuif, France
[2] Inst Gustave Roussy, INSERM, U362, F-94805 Villejuif, France
[3] Inst Gustave Roussy, UMR 1598, F-94805 Villejuif, France
[4] Inst Gustave Roussy, CNRS, UMR 1772, F-94805 Villejuif, France
关键词
TNF; p53; c-myc; Rb;
D O I
10.1038/sj.onc.1202919
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor suppressor p53 is a nuclear transcription factor that blocks cell cycle progression and induces apoptosis, We have previously shown that the MCF7 resistance to the cytotoxic action of TNF correlates with p53 mutations. In the present study, we used a recombinant adenovirus carrying a wild-type p53 gene (Adwtp53) in order to investigate the effect of wt p53 transfer on modulation of cell resistance to the cytotoxic action of TNF. Our data indicate that infection of TNF resistant MCF7 cells (1001 and MCF7/Adr) with Adwtp53 resulted in the restoration of wt p53 expression and function as respectively revealed by the yeast assay and the induction of p53 inducible genes MDM2 and p21, Furthermore, the restoration of p53 function significantly sensitized TNF resistant cells to TNF cytotoxic action. This correlated with a significant don n-regulation of c-myc in both TNF-resistant cell lines and a decrease of Retinoblastoma protein (Rb) in 1001 clone. In contrast, the effect of p53 seems to be independent from Bcl-2 and Bax protein level regulation. The present study suggests that the combination of TNF and Adwtp53 may be a potential strategy to sensitize mutant p53 TNF-resistant tumors to the cytotoxic action of this cytokine.
引用
收藏
页码:5464 / 5472
页数:9
相关论文
共 56 条
  • [1] DEFICIENCY OF RETINOBLASTOMA PROTEIN LEADS TO INAPPROPRIATE S-PHASE ENTRY, ACTIVATION OF E2F-RESPONSIVE GENES, AND APOPTOSIS
    ALMASAN, A
    YIN, YX
    KELLY, RE
    LEE, EYHP
    BRADLEY, A
    LI, WW
    BERTINO, JR
    WAHL, GM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) : 5436 - 5440
  • [2] Inhibition of Bax channel-forming activity by Bcl-2
    Antonsson, B
    Conti, F
    Ciavatta, A
    Montessuit, S
    Lewis, S
    Martinou, I
    Bernasconi, L
    Bernard, A
    Mermod, JJ
    Mazzei, G
    Maundrell, K
    Gambale, F
    Sadoul, R
    Martinou, JC
    [J]. SCIENCE, 1997, 277 (5324) : 370 - 372
  • [3] THE RETINOBLASTOMA PROTEIN COPURIFIES WITH E2F-I, AN E1A-REGULATED INHIBITOR OF THE TRANSCRIPTION FACTOR E2F
    BAGCHI, S
    WEINMANN, R
    RAYCHAUDHURI, P
    [J]. CELL, 1991, 65 (06) : 1063 - 1072
  • [4] MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY
    BARAK, Y
    JUVEN, T
    HAFFNER, R
    OREN, M
    [J]. EMBO JOURNAL, 1993, 12 (02) : 461 - 468
  • [5] Alteration of the sphingomyelin/ceramide pathway is associated with resistance of human breast carcinoma MCF7 cells to tumor necrosis factor-alpha-mediated cytotoxicity
    Cai, ZZ
    Bettaieb, A
    ElMahdani, N
    Legres, LG
    Stancou, R
    Masliah, J
    Chouaib, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (11) : 6918 - 6926
  • [6] Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 function
    Cai, ZZ
    Capoulade, C
    MoyretLalle, C
    AmorGueret, M
    Feunteun, J
    Larsen, AK
    BressacdePaillerets, B
    Chouaib, S
    [J]. ONCOGENE, 1997, 15 (23) : 2817 - 2826
  • [7] Caignard A, 1997, ONCOL REP, V4, P227
  • [8] THE E2F TRANSCRIPTION FACTOR IS A CELLULAR TARGET FOR THE RB PROTEIN
    CHELLAPPAN, SP
    HIEBERT, S
    MUDRYJ, M
    HOROWITZ, JM
    NEVINS, JR
    [J]. CELL, 1991, 65 (06) : 1053 - 1061
  • [9] INTERACTIONS BETWEEN P53 AND MDM2 IN A MAMMALIAN-CELL CYCLE CHECKPOINT PATHWAY
    CHEN, CY
    OLINER, JD
    ZHAN, QM
    FORNACE, AJ
    VOGELSTEIN, B
    KASTAN, MB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) : 2684 - 2688
  • [10] Chiarugi V, 1996, TUMORI, V82, P205